Search results
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 6 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 7 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 2 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 2 days ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant ...
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 3 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 7 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 2 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 6 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...